Soligenix Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
Frequently asked questions
To buy Soligenix Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Soligenix Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Soligenix Inc. is SNGX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Soligenix Inc. has its primary listing on NASDAQ (Small cap). You can trade Soligenix Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Soligenix Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Soligenix Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Soligenix Inc..